Recent published studies show the effectiveness of implementing IntelliSpace Epidemiology and genomic sequencing in infection control. Presented at a major infectious disease conference in 2018, early results have shown an 87 percent reduction in time, when using IntelliSpace Epidemiology, to identify transmissions compared with traditional methods of detection. Another study at an academic medical center looked at the routine use of genomic sequencing for infection control surveillance. Over a six-month period, 19 infection clusters were found using genomic sequencing. Of those 19, only one was detected using traditional techniques.
“Clearly, we need to improve our ability to detect the presence and transmission of bacteria in our hospitals, both resistant and nonresistant organisms,” said Dr. David Classen, MS, FACMI, CMIO, Pascal Metrics, a Patient Safety Organization (PSO), Professor of Medicine, University of Utah; and Consultant in Infectious Diseases and Clinical Epidemiology at The University of Utah School of Medicine. “Traditionally we've had to rely on fairly gross indicators of this problem but that wouldn't necessarily help us understand what kind of transmission is going on in the hospital. Now with whole genome sequencing, we can do this much more accurately and come to some important and quick conclusions that might have taken a much longer time in the past.”
On Wednesday, Feb. 13 at 12:15pm ET, Dr. Classen will speak in the PhilipsLive! Forum at the Philips Booth (#2101) at HIMSS to discuss the topic of “Leveraging HIT as a Clinical Tool for Patient Safety Improvement.” Also on Feb. 13 at 3:45pm ET, Dr. John Fallon, Chairman of Pathology and Professor of Pathology and Medicine at New York Medical College will join Felix Baader in a Fireside Chat to discuss “The Power of Genomics and Informatics; Precision infection Prevention.”
For more information on Philips’ full portfolio of integrated smart enterprise systems, devices, software and services, including the latest news on IntelliSpace Epidemiology that will be spotlighted in Booth #2101 at the HIMSS Global Conference & Exhibition in Orlando, FL, Feb. 11-15, 2019, visit www.philips.com/himss and follow @PhilipsLiveFrom for #HIMSS19 updates throughout the event.
1Reed D, Kemmerly SA. Infection Control and Prevention: A Review of Hospital Acquired Infections and the Economic Implications. The Ochsner Journal. 2009;9(1):27 31.; National Vital Statistics Reports vol. 65 number 5 2016
2Zimlichman E, et. al. Health Care–Associated Infections: A Meta-analysis of Costs and Financial Impact on the US Health Care System, JAMA Intern Med. 2013;173(22):2039-2046.
3Chen, Donald et al. “Genomic Sequencing and Clinical Data Integration for Next-Generation Infection Prevention” Open Forum Infectious Diseases vol. 5,Suppl 1 S379–S380. 26 Nov. 2018, doi:10.1093/ofid/ofy210.1081
4Ellison, Richard T et al. “Utility of Routine Genomic Sequencing for Infection Control Surveillance” Open Forum Infectious Diseases vol. 4,Suppl 1 S35. 4 Oct. 2017, doi:10.1093/ofid/ofx162.086